论文部分内容阅读
原发性肝癌在无普查条件下的切除率仍徘徊在20%左右,对80%左右不能手术切除的病例的治疗仍然是今后治疗的重点课题。本文为1989年12月~1991年4月期间所做的前瞻性观察。用含甲氨喋呤白蛋白微球肝动脉末梢栓塞治疗不能手术切除的中晚期肝癌19例,从癌灶大小、甲胎蛋白动态变化等临床资料初步总结,肯定了这一治疗方法的优越性。
The resection rate of primary liver cancer in the absence of census is still hovering around 20%. The treatment of about 80% of unresectable cases is still a key topic for future treatment. This article is a prospective observation from December 1989 to April 1991. Endometrial embolization using methotrexate albumin microspheres in the hepatic artery was used to treat 19 patients with unresectable advanced hepatocellular carcinoma. The clinical data, including the size of the foci and the dynamic changes of alpha-fetoprotein, were initially summarized, confirming the superiority of this treatment. .